Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Copaxone®
01.05.1998
Prof. Ephraim Katzir reminisces about the last 50 years of the Weizmann Institute
01.05.1997
Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS
13.04.1997
Weizmann Institute's Prof. Michael Sela First Israeli Winner of Interbrew-Baillet Latour Health Prize
...
28.01.1997
REHOVOT, Israel -- January 28, 1997 -- This week, two scientists from Israel's Weizmann Institute were honored for an...
23.12.1996
REHOVOT, Israel -- December 23, 1996 -- The U.S. Food and Drug Administration today announced the approval of the Israeli...
19.09.1996
REHOVOT, Israel -- September 19, 1996 -- An advisory committee convened by the U.S. Food and Drug Administration...
